कृपया अन्य खोज का प्रयास करें
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer’s disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson’s disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer’s disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, which is phase 1 clinical trial that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313 that targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Thomas P. Monath | 83 | 2022 | Member of Science Advisory Board |
Louis Garfield Reese | 42 | 2014 | Co-Founder & Executive Chairman of the Board |
Peter H. Diamandis | 63 | 2021 | Non-Employee Independent Director |
Stephen Nicholls | - | 2023 | Member of Scientific Advisory Board |
George Ronald Hornig | 70 | 2022 | Independent Director |
Richard Mohs | - | - | Member of Scientific Advisory Board |
Jeffrey L. Cummings | 74 | - | Member of Scientific Advisory Board |
Landon Ogilvie | 46 | 2023 | Lead Independent Director |
Frederick Raal | - | 2023 | Member of Scientific Advisory Board |
Kausik K. Ray | - | 2023 | Member of Scientific Advisory Board |
Stanley A. Plotkin | 91 | - | Member of Scientific Advisory Board |
Dirk Von Lewinski | - | 2023 | Member of Scientific Advisory Board |
Eric M. Reiman | - | - | Member of Scientific Advisory Board |
Nick Fox | - | - | Member of Scientific Advisory Board |
Wayne C. Koff | - | - | Member of Scientific Advisory Board |
James Alan Smith | 43 | 2023 | Independent Director |
Gabrielle B. Toledano | 57 | 2023 | Independent Director |
Parviz Ghahramani | - | 2023 | Member of Scientific Advisory Board |
Stephen D. Silberstein | - | 2023 | Member of Scientific Advisory Board |
Brad Boeve | - | - | Member of Scientific Advisory Board |
Mei Mei Hu | 41 | 2014 | CEO & Director |
Thomas Fleming | - | 2023 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है